SCHEMBL18152659

SCHEMBL18152659

Cc1nc2c(CS(C)(=O)=O)c(CC3CC3)c(Br)cc2[nH]1

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ ADRB2 P07550 1/20 0.33
▸ HTT P42858 1/20 0.32
▸ DHODH Q02127 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18152624 0.81 HTT (0.33) ADRB2HTT
SCHEMBL18152712 0.78 GRIN2D (0.38) HTT
SCHEMBL18152662 0.70 SCN9A (0.33) —
SCHEMBL18152677 0.69 CCNB2 (0.32) —
SCHEMBL18152633 0.68 USP30 (0.34) —
SCHEMBL18152783 0.65 RIPK1 (0.33) HTT
SCHEMBL4381077 0.62 HTT (0.47) HTTDHODH
SCHEMBL24589284 0.61 ALDH1A1 (0.50) —
SCHEMBL15023422 0.60 HTT (0.44) HTTDHODH
SCHEMBL21905305 0.59 DHODH (0.70) DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3283077-A2 BROMODOMAIN INHIBITOR Celgene Quanticel Research, Inc. (US) 2018-02-21 — — EP disclosed
WO-2016168682-A2 BROMODOMAIN INHIBITOR CELGENE QUANTICEL RESEARCH, INC. (US) 2016-10-20 — — WO disclosed
Send feedback